Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 30 studies | 29% ± 10% | |
mast cell | 19 studies | 25% ± 8% | |
macrophage | 19 studies | 26% ± 11% | |
plasmacytoid dendritic cell | 12 studies | 33% ± 9% | |
endothelial cell of artery | 12 studies | 25% ± 11% | |
capillary endothelial cell | 11 studies | 24% ± 11% | |
vein endothelial cell | 10 studies | 26% ± 11% | |
platelet | 9 studies | 43% ± 15% | |
myeloid cell | 9 studies | 27% ± 7% | |
endothelial cell of lymphatic vessel | 9 studies | 24% ± 5% | |
endothelial cell of vascular tree | 8 studies | 23% ± 8% | |
B cell | 7 studies | 19% ± 3% | |
megakaryocyte | 6 studies | 63% ± 25% | |
dendritic cell | 5 studies | 27% ± 16% | |
type B pancreatic cell | 4 studies | 44% ± 10% | |
classical monocyte | 4 studies | 25% ± 5% | |
conventional dendritic cell | 4 studies | 34% ± 10% | |
non-classical monocyte | 4 studies | 23% ± 6% | |
erythroblast | 4 studies | 34% ± 10% | |
plasma cell | 4 studies | 32% ± 12% | |
monocyte | 4 studies | 21% ± 2% | |
cardiac muscle cell | 4 studies | 25% ± 5% | |
memory B cell | 4 studies | 16% ± 0% | |
naive B cell | 4 studies | 17% ± 1% | |
hematopoietic precursor cell | 3 studies | 27% ± 10% | |
plasmablast | 3 studies | 42% ± 12% | |
pancreatic A cell | 3 studies | 28% ± 5% | |
pancreatic D cell | 3 studies | 37% ± 19% | |
GABAergic neuron | 3 studies | 35% ± 11% | |
glutamatergic neuron | 3 studies | 44% ± 12% | |
megakaryocyte-erythroid progenitor cell | 3 studies | 47% ± 18% | |
alveolar macrophage | 3 studies | 23% ± 7% | |
erythrocyte | 3 studies | 40% ± 14% | |
hematopoietic stem cell | 3 studies | 31% ± 17% | |
adipocyte | 3 studies | 24% ± 8% | |
microglial cell | 3 studies | 17% ± 3% | |
neuron | 3 studies | 24% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 99% | 1877.75 | 243 / 245 | 100% | 12.15 | 500 / 502 |
breast | 100% | 2812.90 | 459 / 459 | 98% | 11.46 | 1095 / 1118 |
kidney | 99% | 1624.45 | 88 / 89 | 97% | 15.30 | 871 / 901 |
skin | 95% | 1953.96 | 1727 / 1809 | 100% | 53.79 | 472 / 472 |
lung | 100% | 2618.35 | 577 / 578 | 95% | 10.47 | 1096 / 1155 |
brain | 98% | 1866.33 | 2598 / 2642 | 93% | 7.97 | 658 / 705 |
ovary | 100% | 2230.90 | 180 / 180 | 87% | 6.76 | 375 / 430 |
adrenal gland | 100% | 2405.99 | 258 / 258 | 87% | 10.68 | 200 / 230 |
stomach | 94% | 1074.23 | 336 / 359 | 90% | 10.90 | 256 / 286 |
intestine | 98% | 1946.11 | 950 / 966 | 84% | 11.43 | 441 / 527 |
thymus | 98% | 1248.82 | 640 / 653 | 84% | 7.29 | 508 / 605 |
uterus | 99% | 2227.84 | 169 / 170 | 76% | 8.12 | 348 / 459 |
esophagus | 88% | 1876.30 | 1276 / 1445 | 86% | 8.12 | 157 / 183 |
bladder | 100% | 2409.33 | 21 / 21 | 73% | 8.96 | 368 / 504 |
pancreas | 55% | 420.05 | 181 / 328 | 95% | 13.55 | 169 / 178 |
liver | 57% | 477.54 | 129 / 226 | 80% | 9.67 | 325 / 406 |
adipose | 100% | 3413.41 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 69.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 22.83 | 29 / 29 |
muscle | 100% | 10367.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3011.56 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 4590.24 | 860 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 95% | 3856.29 | 882 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 89% | 8.96 | 40 / 45 |
blood vessel | 77% | 871.22 | 1025 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007163 | Biological process | establishment or maintenance of cell polarity |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0030031 | Biological process | cell projection assembly |
GO_0071963 | Biological process | establishment or maintenance of cell polarity regulating cell shape |
GO_0034446 | Biological process | substrate adhesion-dependent cell spreading |
GO_0030032 | Biological process | lamellipodium assembly |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0030018 | Cellular component | Z disc |
GO_0030027 | Cellular component | lamellipodium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
Gene name | PARVB |
Protein name | Beta-parvin (Affixin) Parvin beta |
Synonyms | CGI-56 |
Description | FUNCTION: Adapter protein that plays a role in integrin signaling via ILK and in activation of the GTPases CDC42 and RAC1 by guanine exchange factors, such as ARHGEF6. Is involved in the reorganization of the actin cytoskeleton and formation of lamellipodia. Plays a role in cell adhesion, cell spreading, establishment or maintenance of cell polarity, and cell migration. . |
Accessions | B0QYP8 ENST00000404989.1 [Q9HBI1-3] ENST00000338758.12 [Q9HBI1-1] ENST00000619710.4 A0A087WZB5 ENST00000444029.5 Q9HBI1 ENST00000406477.7 [Q9HBI1-2] |